admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of...

PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified

Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1...

First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics...

Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II...

Psyence Group Announces Closing of Fourth Tranche of Private Placement and...

Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA...

Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference...

1...747576...218 Page 75 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin